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CHAPTER 1. GENERAL INTRODUCTION 
 Human health professionals have long been concerned with 
microorganism gaining resistance to antimicrobials and antibiotics commonly 
used to treat and prevent infections. Antibiotic resistant bacteria have a genetic 
make-up different than antibiotic susceptible organisms, which allows them to 
survive antibiotic treatments and other potential stressors in their environment 
that would have otherwise been lethal. Methicillin-resistant Staphylococcus 
aureus, or MRSA, is just one of many species of bacteria that have adapted to a 
specific class of antibiotics. MRSA has gained notoriety over other antibiotic 
resistant species, because it seems to be so ubiquitous in our environment.  
Bacterial resistance not only affects human health, but also domesticated 
pets and livestock. Antibiotics used to treat disease in pets and livestock are 
similar, and in some cases exactly the same, as those antibiotics prescribed by 
physicians in human health. This practice is not alarming, since the common 
mircoflora of both humans and animals can be identical. If a drug works well in 
one animal for a specific organism of interest causing an infection, it makes 
sense that the same antibiotic or antimicrobial will be as effective for the same 
bacteria in a different host species.  
The main problem with antibiotic resistance in livestock species is the fact 
that they are utilized for meat and milk. The issue of antibiotic resistance in 
livestock and poultry health is very complex when compared to human health, 
because of the fact that they provide essential nutrition for humans. Livestock 
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and poultry species have sustained human life for generations, and ensuring the 
safety of these commodities is paramount to support life for future generations. 
Production practices for livestock have also changed since the first meat 
animal species were domesticated. Livestock and poultry production practices 
are managed more intensely today. Production operations, along with genetic 
selection, allow for increased growth and efficiency of the species being 
produced for meat or milk. Modern animal production farms are very large in 
scale and productivity when compared to the smaller, but more numerous, family 
farms in this country at the turn of the 20th century. Opponents of modern animal 
agriculture would argue that it is these production practices that now threaten 
human life instead of preserving it.  
        Meat and poultry, especially pork, have been found to be positive for 
MRSA, and prevalence of MRSA in meat at the retail level is much higher than 
originally thought. This can be quite alarming since the mechanism of how this is 
occurring is not well understood.  Staphylococcal aureus intoxication has long 
been associated with foodborne illness around the world, however, very little is 
known about it’s antibiotic resistant relative with respect to food safety. Although 
earlier studies sought to discover the presence of MRSA in meat, the survival of 
MRSA during thermal processing is not well understood. Therefore, the overall 
objective of this research was to determine the potential for MRSA survival 
during thermal lethality processes common to produce pork. The first objective 
investigated the survival of MRSA during commercial thermal processing. The 
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second objective evaluated MRSA survival during common consumer cooking 
methods for pork.   
Dissertation Organization 
This dissertation is organized into five chapters. Chapter 1 is a general 
introduction. Chapter 2 is a review of literature pertinent to the objectives of this 
research project. Chapter 3 is a manuscript to be submitted to Foodborne 
Pathogens and Disease entitled “Survival of methicillin-resistant Staphylococcus 
aureus during commercial thermal processes for frankfurters, summer sausage 
and ham”. Chapter 4 is a manuscript to be submitted to Journal of Food 
Protection entitled “Survival of methicillin-resistant Staphylococcus aureus during 
commercial heat treatment of slab bacon and consumer frying of sliced bacon”. 
References, figures and tables referred to in the literature review and 
manuscripts will be at the end of each chapter. Chapter 5 provides a general 
summary of the research project and final conclusions for the obtained results.  
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CHAPTER 2. LITERATURE REVIEW 
Staphylococcus 
Genus 
The genus Staphylococcus is a group of microorganisms that test positive 
for gram staining and appear, under the microscope, blue to purple in color from 
the absorption of the stain by the thick peptidoglycan layer component of the 
bacterial cell wall (Reaveley and Burge 1972, Beveridge 2000). Staphylococci 
are small cocci or round cells that are usually arranged in pairs and small 
irregular clusters of cells (3 to 4). The word Staphylococcus stems from the 
Greek word “σταφύλια” (staphylia), which means “bunch of grapes” 
(Stavropoulos and Hornby 2008). This is why some texts and documents refer to 
these organisms as being arranged in “grape-like clusters” of cells (ICMSF 1996, 
FDA 2012a). Staphylococci are facultative anaerobes, which mean these 
organisms can utilize both aerobic and anaerobic metabolic pathways, 
depending on the presence or absence of oxygen in their environment. 
Organisms from this genus are catalase positive, or have the ability to change 
hydrogen peroxide (2 H2O2) into water (2 H2O) and oxygen (O2). Staphylococci 
have a low percentage (30% – 39%) of guanine plus cytosine (G+C) in their 
genetic make-up when compared to other gram positive cocci (Prescott et al. 
1996).  
Taxonomy 
        Some people still recognize bacteria as either ‘good’ or ‘bad’, but 
modern classification of microorganisms didn’t really begin until the American 
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society for microbiology published the first edition of Bergey’s Manual in 1923 
(Bergey 1923). That first edition of the manual listed only six species of the 
genus Staphylococcus. Today, almost forty species (depending on the source) 
are assigned to the genus by well-defined genotypic and phenotypic criteria (De 
Vos et al. 2009). Genotypic evaluation of all species can be performed using 
ribosomal RNA. The ribosome is the site of protein synthesis in a cell. Literature 
refers to the use of the 16s subunit of rRNA (Takahashi et al. 1999) to be able to 
sequence and classify members of the Staphylococcus genus. The 16s genetic 
code is unique for each identified species and is compared to a known database 
during evaluation and naming. Even though numerous species, sub-species and 
strains have been identified since Bergey’s systematic approach began, only two 
species (S. aureus and S. epidermis) are really known to be associated with 
human diseases.  
Staphylococcus spp. causing human disease 
Staphylococcus epidermis 
One of the two Staphylococcal species associated with human disease 
and infection is S. epidermis. S. epidermis is a lesser known pathogen 
recognized by the general public, and as its name suggests, is commonly found 
on the skin of humans. S. epidermis has been associated with infections of the 
heart valves, skin lesions and other minor infections (Heilmann and Peters 2000). 
S. epidermis does not possess the ability to clot rabbit plasma and is classified in 
a Staphylococcal group as coagulase negative. The coagulase test is a 
phenotypic method used to classify Staphylococcal species and will be explained 
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in more detail in a following section. According to a review by Kloos and 
Bannerman (1994), most infections caused by coagulase negative Staphylococci 
(mainly S. epidermis) are acquired in a nosocomial setting. 
Staphylococcus aureus  
The second and more severe pathogenic Staphylococcal species 
associated with human disease is S. aureus. According to Prescott et al. (1996), 
“S. aureus is the most important human Staphylococcal pathogen”. S. aureus is 
resistant to high salt concentrations (10-15%) and temperatures of 50°C or more 
(Smith and Marmer 1991). This ubiquitous microorganism is commonly found in 
the nasal passage, mucous membranes and on the skin of humans (Williams 
1963). S. aureus is non-motile, non-spore forming and infections tend to be 
pyogenic or pus forming in nature. Unlike S. epidermis, S. aureus is coagulase 
positive. Human S. aureus infections included the following: impetigo, folliculitis, 
endocarditis, pneumonia and various bone and joint infections. 
The Coagulase test 
The coagulase test tends to be one of the main determinants for 
classifying unknown species of Staphylococci. The ability to clot rabbit plasma in 
a test tube or on a microscope slide is a widely accepted method to 
phenotypically identify unknown, gram positive cocci as S. aureus. Clotting 
factors of the enzyme’s activity react with plasma components fibrinogen and/or 
thrombin. Agglutination or clumping factor is a visible reaction between the bound 
coagulase (intracellular) and fibrinogen component of the plasma. These two 
components cross link to form fibrin on the cell wall of the bacterial cell and 
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immediately allow cocci to bind together or “clump” and separate from the 
remaining plasma fraction.    
Extracellular coagulase reacts similarly with thrombin in test tube plasma. 
The combined thrombin allows reaction with fibrinogen to again cross link and 
form fibrin. The clumping or grouping of cocci in a tube is similar to results seen 
on a slide (Arvidson 2000). 
Prevalence and carriage of S. aureus 
S. aureus is very prevalent in our society, especially in health care 
facilities, and carriage rates of human populations have been reported to range 
between 29% – 51% (Williams 1963, Wenzel and Perl 1995). High risk groups, 
like health care workers and hospital employees, have been documented to have 
carriage rates as high as 90% (Tenover and Gaynes 2000). Results between S. 
aureus carriage studies of healthy human populations can vary depending on 
how swab samples were taken and the anatomical location of the sample. 
Prevalence of S. aureus carriage seems to be affected by age and health of 
normal populations, but does not appear to have seasonality trends (Noble et al. 
1967). Infections caused by S. aureus have “higher morbidity and mortality” when 
compared to other bacteremia rates (Naber 2009).  
S. aureus Infections in Humans 
S. aureus infections in humans are thought to be initiated by invasion of 
the bacteria through a wound, open skin or soft tissue. This pathogen is also 
associated with infections from medical procedures, such as surgical incisions 
and catheterizations. Infection appears to be linked to carriage of the bacteria. 
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Impetigo 
 Impetigo is a highly contagious skin infection commonly seen in infants 
and young children. This type of infection can be caused by S. aureus and may 
result from skin associated trauma, for example an abrasion from falling, an 
insect or animal bite and other disruptions of the outer dermal layer, allowing 
opportunistic bacteria to invade. Symptoms of the infection appear as large, pus 
filled blisters or bullae (Vorvick 2010) usually on the face and around the mouth. 
Once breakage of these bullae occurs, the remaining infected area appears as a 
red, sometimes itchy rash that can easily be propagated by scratching. Other 
symptoms include swelling of the lymph nodes and skin lesions.  Antibacterial 
creams are prescribed as treatment, and in more severe infections, antibiotics 
will be administered orally (WebMD 2010).   
Folliculitis 
 Folliculitis is a dermatological infection of the skin and surrounding hair 
follicle. Causes of this infection include cuts from shaving and severe friction from 
clothing rubbing against the skin causing potential irritation and blockages of the 
hair follicle. Symptoms include small pustules around an infected hair follicle or a 
red, itchy rash on the skin surrounding the follicle. Treatment of these minor skin 
infections is usually non-invasive, since the infected skin area is usually 
localized. Antibiotic ointments, topical antifungal creams and hot compresses are 
common treatments with symptoms subsiding in two to three days (Vorvick and 
Zieve 2010).  
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Bacterial Endocarditis 
 Endocarditis is a severe and invasive infection of the innermost layer of 
the heart and heart valves caused by S. aureus. This severe illness usually 
occurs from bacterial carriage of S. aureus entering the blood stream and 
attaching to the surface of a congenital malformation of the heart muscle or 
defective valve. Routine oral prophylaxis is a major source of S. aureus entering 
the circulatory system.  Once infection is diagnosed, severe damage to the heart 
and heart valves can occur from the propagation of S. aureus in the affected 
area. Symptoms of bacterial endocarditis usually begin with high, persistent fever 
and also include loss of appetite, joint pain and general lethargy.  According to 
Brookfield (1994), bacterial endocarditis may result from any number of heart 
related malformations, “but is most common in aortic valve lesions.” An antibiotic 
administered orally is generally the prescribed method for prevention prior to 
dental visits for children and young adults with known congenital heart defects. 
Treatment of this infection is usually fairly invasive and requires intravenous 
antibiotics to be administered by a health professional (Brookfield 1994, Fox 
2010). 
Bone and Joint Infections 
 Osteomyelitis and septic arthritis are two of the most common bone and 
joint afflictions caused by an S. aureus infection. In many cases, osteomyelitis 
occurs as a result of a secondary infection from S. aureus in the vascular system. 
According to a recent article in Best Practice and Research Clinical 
Rheumatology, the majority of clinical cases occur in the feet, vertebral column 
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and long bones of the human body (Sia and Berbari 2006). Individuals with 
increased risk factors for osteomyelitis include patients recovering from surgery, 
those with diabetes, the immunocompromised and habitual intravenous drug 
users (Chihara and Segreti 2010). Early onset symptoms are similar to the flu 
and include joint pain, high fever, chills and general lethargy. Although infection 
rates are low due to the protective properties of bone, morbidity of the disease 
can be significant. In many cases, the infection is not localized but spreads to 
infect other soft tissue areas surrounding the initial bone site. Diagnosis is usually 
confirmed via blood test for suspecting microorganisms, bone biopsy and the use 
of magnetic resonance imaging. The infection is usually treated with intravenous 
antibiotics for four to six weeks. Recovery is slow and relapse rates of infection 
are estimated to be around 20% and depends on the risk factors of the individual 
afflicted (Sia and Berbari 2006, Chihara and    Segreti 2010). 
 Septic arthritis or infectious arthritis is an infection and inflammation of the 
joint caused by S. aureus. Infection usually occurs as a result of joint surgery or 
can be spread directly to the joint by the vascular system. According to Dugdale 
et al. (2011), “the most common sites for … infection are the knee and hip.”  
Prompt diagnosis and subsequent antibiotic therapy is the key for a good 
prognosis of the patient (Dugdale et al. 2011).  
Pneumonia    
Bacterial pneumonia, an infection of the lungs, is predominantly caused by 
S. aureus. Those individuals most at risk for contracting bacterial pneumonia are 
the elderly (> 65 years of age) and infants under the age of two. Pneumonia is 
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typically grouped into categories by origination of the infection. Kollef and Micek 
(2005), give examples of these groups by describing pneumonia contracted in 
nosocomial settings, health care facilities or at home. According to CDC’s 
National Center for Health Statistics (2012b), greater than 1 million patients are 
hospitalized for pneumonia annually and the nosocomial mortality rate is around 
3.4%. Diagnosis occurs through the use of x-ray technology, sputum culture 
results and blood test confirmation. As with most bacterial infections, antibiotic 
therapy is the preferred treatment (Kollef and Micek 2005).  
S. aureus has been also been researched for disease caused by the toxin 
some strains produced. Several toxins are produced by S. aureus and cause a 
wide variety of illnesses. 
S. aureus toxin production 
 S. aureus produces a number of toxins both inside and outside of the cell 
that cause human illness. Some of the toxins that are produced include alpha, 
beta, gamma, delta and leucocidin. Most of these cell toxins cause damage to 
the plasma membrane of healthy cells, which ultimately leads to damage of 
healthy tissues and cell death (Fox 2010). 
Alpha toxin 
 Alpha (α) toxin, a short chain protein secreted by most S. aureus strains, 
was the first pore forming toxin discovered in the bacterial species. Α-toxin 
interacts directly with healthy cell membranes by integrating itself into the plasma 
membrane and creating a channel or “pore” for free ion exchange into and out of 
the cell, typically human epithelial cells. This channel creates a severe osmotic 
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imbalance and exchange of ions and ultimately results in lysis of the cell. 
(Bhakdii and Tranum-Jensen 1991, Bohach and Foster 2000, Fox 2010). 
Beta toxin 
 Beta (β) toxin is another virulence factor located on the cell surface and 
secreted outside of the bacterial cell by some strains of S. aureus. This small 
protein (~34KDa) is recognized by researchers as the “hot-cold toxin” (Huseby et 
al. 2007), because of the protein’s unique ability to bind with sheep blood cells at 
37°C, but not lyse them until the erythrocytes are maintained at 4°C. Β–toxin is 
also known for its neutral sphingomyelinase activity, which attaches to and 
damages lipids in the plasma membrane of cells. The enzyme activity is 
enhanced in the presence of certain cations, for example Ca2+ (Bohach and 
Foster 2000, Huseby et al. 2007, Fox 2010).     
Gamma toxin 
 Gamma (Γ) toxin, like a-toxin, is a pore forming protein made by most 
strains of S. aureus that damages the plasma membrane of healthy neutrophils 
and macrophages (Fox 2010). Γ-toxin differs from a-toxin (single chain) in that it 
is made up of two polypeptide chains (S and F). These protein side chains are 
encoded for genetically by the hlg loci (HlgA = S chain and HlgB = F chain) that 
is carried by most S. aureus strains. These two proteins are categorized by ion 
exchange to be either fast (F) or slow (S). These two proteins are hemolytic in 
nature and work synergistically to disrupt cell homeostasis. Γ-toxin has also been 
found to interact with other Staph. toxins that cause specific human illnesses 
(Nilsson et al. 1999, Bohach and Foster 2000, Fox 2010). 
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Delta toxin 
 Delta (Δ) toxins are small proteins produced by most strains of S. aureus 
that damage the lipid bi-layer of cell membranes. Δ-toxin acts like a detergent 
when interacting with cell membranes and causes “cytoplasmic leakage and lysis 
of cells” (Bohach and Foster 2000). Similar to Γ-toxin, Δ-toxin enhances other 
factors related to human disease (Schmitz et al. 1997, Bohach and Foster 2000, 
Fox 2010). 
Leukocidins 
 Leukocidins are very similar in structure, function and genetic encoding as 
Γ-toxin. Instead of the hlg loci, leukocidins are encoded for by the luk gene, a 
virulence factor not common to most strains of S. aureus. Unlike Γ-toxin, 
however, leukocidin does not posses hemolytic capability (Bohach and Foster 
2000, Fox 2010).    
S. aureus toxin mediated disease 
 Many human illnesses are initiated by S. aureus infections, but some of 
the most feared are those diseases initiated by toxins that the microorganism 
produces. S. aureus has been extensively researched for both exotoxin and 
enterotoxin production with regard to human diseases mediated by these toxic 
proteins.   
Toxic Shock Syndrome 
 Toxic Shock Syndrome (TSS) is a human disease initiated by the 
superantigen TSST-1. Toxic Shock Syndrome Toxin is historically associated 
with tampon use by females during menstruation, but TSS can also be 
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nonmenstrual in nature and result from a wound (Bohach and Foster 2000). 
Symptoms of the disorder include vomiting, diarrhea, fever, peeling rash and 
decreased blood pressure. TSS is systemic in nature and is generally difficult to 
diagnose. TSST-1 causes an immune response when interacting with T-
lymphocytes that ultimately induces an abnormally high cytokine production. 
Cytokines are cell signals that trigger inflammation and mediate the development 
of TSS (Bohach and Foster 2000, Fox 2010, Lowy 2010).  
Scalded Skin Syndrome 
 A second disease mediated by S. aureus toxin production is 
Staphylococcal Scalded Skin Syndrome (SSSS), also known as Ritter disease. 
This disorder is generally caused by one of two types of exfoliative toxins (ExTA 
and ExTB) that act as proteases on human skin epithelial cells (Fox 2010). The 
main result of this protease activity is similar to the sloughing or sheeting of skin 
layers seen in TSS and the skin appears to be blistered or scalded (Lowy 2010). 
Fever is also a common symptom of the disorder. Patients with SSSS test 
positive for Nikolsky’s sign or the ease of skin peeling or sheeting with minor 
pressure (Fox 2010). Intravenous antibiotics and fluids are administered to 
patients with symptoms subsiding in about seven to ten days (Bohach and Foster 
2000, Fox 2010, Lowy 2010).  
Enterotoxicosis by S. aureus 
 Enterotoxicosis or classical Staphylococcal food poisoning is caused by 
Staphylococcal enterotoxins (SEs). There are nine major heat stable enterotoxins 
that have been discovered to date (Balaban and Rasooley 2000). Staphylococcal 
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enterotoxicosis is contracted by consuming food that is contaminated by SEs 
secreted into the food by various toxin producing strains of S. aureus. According 
to Cassman (1965), SEA is the most common toxin related to SE food poisoning, 
accounting for almost 78% of all cases investigated. Table 1 lists the types of 
SEs and the gene that encodes for these single chain polypeptide superantigens. 
  
Table 1. List of SE superantigens and encoding genes 
Staphylococcal Enterotoxin # of Amino Acids Gene 
SE-A 233 entA 
SE-B 240 entB 
SE-C 
Subtypes: SE-C1, SE-C2 & SE-C3 
C1-230 
C2-239 
C3-240 
 
entC1, entC2 & entC3 
SE-D 228 entD 
SE-E __ entE 
SE-G 233 entG 
SE-H __ entH 
SE-I 218 entI 
SE-J 248 entJ (same plasmid as SE-D) 
     Source: Balaban, N and Rasooley, A. 2000. Intl J Food Micro 61(1)1-10. 
Symptoms of Enterotoxicosis 
 According to Bennett and Hait (2011), clinical symptoms of the intoxication 
occur within two to six hours after ingesting the toxin. It is unknown what the 
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thresholds for each toxin are, but it was estimated that patients who became ill 
ingested at least 100ng of the virulent protein (Evenson et al. 1988). In addition 
to surviving very high temperatures (boiling for 30 min), enterotoxins are resistant 
to normal digestive proteases (e.g. pepsin and trypsin) found in the 
gastrointestinal tract to help digest proteins. Signs of the intoxication include 
nausea, vomiting, diarrhea and gastroenteritis, however, no fever is observed. 
Since enterotoxicosis does not involve viable pathogens, antibiotics are not 
necessary to treat symptoms. Fluid therapy to prevent dehydration is generally 
the means of treatment (Fox 2010). 
Enterocolitis 
 Enterocolitis is a condition similar to Staphylococcal food poisoning with 
one major difference, the infection of viable S. aureus cells in the gut. Symptoms 
of this infection are similar to that of enterotoxicosis, but include fever. Since this 
illness is associated with live bacteria, antibiotic therapy is the preferred course 
of treatment after positive identification of the microorganism has been confirmed 
from the patient’s stool sample (Fox 2010).   
Foodborne Illness in the United States 
 Foodborne illness in the United States is a major concern for public health 
experts. Although regulations for food processors are constantly increasing and 
more restrictive legislation passed to secure the safety of the food supply, 
millions of people report illness from food consumption annually. It has been 
estimated that 75 – 80 million people become ill each year from consuming food 
products (Mead et al. 1999, Balaban and Rasooley 2000). According to CDC 
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(2011) however, it was estimated that human illness in 2011 from foodborne 
agents would be around 48 million cases. Foodborne illnesses result in 5,000 – 
9,000 deaths annually with an economic impact estimated to be greater than 6 
billion dollars to the industry (Altekruse 1997, Buzby and Roberts 1997, Mead et 
al. 1999). Unfortunately, underreporting of illness makes these estimates and 
projected economic figures inaccurate (Mead et al. 1999). There are many 
reasons why a consumer would choose not to report an illness contracted from a 
food product, but this major flaw still lies in the heart of how foodborne illness 
data are gathered, investigated and reported.    
Burden of Illness pyramid 
 The burden of illness pyramid is a model to outline how foodborne 
illnesses are reported in the United States (Figure 1). Centers for disease control 
actively monitor foodborne illness cases through the active surveillance network 
called FoodNet (CDC 2012a). Unfortunately, active surveillance alone represents 
only a small portion of a specific population that became ill. An “outbreak” is 
defined as two or more people presenting to a medical professional with common 
symptoms and food commonalities (CDC 2012a).   
The pyramid model was designed to encompass a more accurate 
estimate of the population by providing data from the general population, 
physician questionnaires and laboratory surveys as foodborne illness data moves 
up the pyramid (FSIS 1998).  
One of the main flaws with any model is estimating for unknowns. In the 
burden of illness pyramid model, FoodNet attempts to estimate for 
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underreporting by consumers and illnesses contracted from unknown agents. 
Underreporting can occur at any step in the pyramid model, but would generally 
begin at step three of the pyramid (FSIS 1998, CDC 2012a). Step three, “seeking 
medical care”, may be avoided by consumers for many reasons. Using S. aureus 
as an example, the quick onset and duration of an intoxication episode could 
lead to an individual enduring the symptoms without seeking medical assistance. 
This type of underreporting of illness decreases the accuracy of actual incidence 
of foodborne illness in a population (Mead et al. 1999) and could be much higher 
than believed for an organism like S. aureus.  
   
Figure 1. Burden of Illness Pyramid 
 
Source: USDA Food Safety & Inspection Service 2008  
http://www.fsis.usda.gov/ophs/rpcong98/rpcong98.htm 
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Incidence of S. aureus Foodborne Illness 
 According to a review by Balaban and Rasooley (2000), S. aureus and SE 
production in food was one of the most common (2nd) causes of foodborne illness 
in the United States. This trend in disease from consumption of contaminated 
food products is fairly static from the years 1983 through the mid 1990s and then 
rates appear to decrease in the number of cases reported (Bean et al. 1990, 
1996). Table 2 shows CDC estimates for foodborne illness in the U.S. for 2011. 
Table 2. Estimated annual number of domestically acquired, foodborne 
illnesses, hospitalizations, and deaths due to 31 pathogens and 
unspecified agents transmitted through food, United States. 
Foodborne 
Agents 
Estimated 
annual number 
of illnesses  
(90% credible 
interval) 
% 
Estimated 
annual number 
of 
hospitalizations  
(90% credible 
interval) 
% 
Estimated 
annual 
number of 
deaths  
(90% credible 
interval) 
% 
31 known 
pathogens 
9.4 million  
(6.6–12.7 
million) 
 
20 
 
55,961  
(39,534–75,741) 
44 
1,351  
(712–2,268) 
44 
Unspecified 
agents 
38.4 million 
(19.8–61.2 
million) 
80 
71,878  
(9,924–157,340) 
56 
1,686 
(369–3,338) 
56 
Total 
47.8 million  
(28.7–71.1 
million) 
100 
127,839 
(62,529–215,562) 
100 
3,037  
(1,492–4,983) 
100 
Source: CDC 2011. http://www.cdc.gov/foodborneburden/2011-foodborne-estimates.html. 
 
 
 More recent trends for foodborne illness in the U.S. indicate that S. aureus 
has dropped from near the top of causal food agents to the fifth most common 
pathogen known to be attributed to foodborne illness. Table 3 outlines the current 
top five pathogens attributed to foodborne illness in the United States (CDC 
2011). 
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Although these estimates seem to show that S. aureus mediated illness 
via food consumption has decreased over the past few decades, actual percent 
of reported cases has remained fairly steady at around 2.5 to 3% (Bean et al. 
Table 3. Top five pathogens contributing to domestically acquired 
foodborne illnesses  
Pathogen 
Estimated number of 
illnesses 
% 
Norovirus 5,461,731  58 
Salmonella, nontyphoidal 1,027,561  11 
Clostridium perfringens 965,958 10 
Campylobacter spp. 845,024  9 
Staphylococcus aureus 241,148  3 
Subtotal  8,541,422 91 
 Source: CDC 2011. http://www.cdc.gov/foodborneburden/2011-foodborne-estimates.html. 
 
 
1990, 1996, CDC 2011). Also, rates of foodborne illness attributed to the 
pathogen S. aureus could be deceiving due to severe underreporting of illness by 
affected consumers due to the short onset (2 to 6h) and duration of symptoms 
(24-48h) (Mead et al. 1999, Bohach and Foster 2000). Since the main course of 
treatment for enteritis caused by SE is fluid therapy to prevent dehydration, 
patients may choose to suffer through milder symptoms while providing 
appropriate auto-replenishing of lost fluids. This makes accurate reporting of the 
intoxication difficult.  
Foods contributing to S. aureus foodborne illness 
 American consumers have drastically changed their eating habits in the 
past twenty to thirty years. According to Doyle (2010), “About one-third of food 
dollars was spent eating away from home in 1970, whereas in 1996, 46% of food 
 21 
dollars went to meals and snacks prepared outside the home.” From this 
dramatic increase in food eaten outside of the home, it could be perceived that 
restaurants and food service establishments possess most of the burden of 
foodborne illness. Wieneke et al. (1993) however, indicated that most foodborne 
illness attributed to S. aureus or SE occurred in the home. It was concluded from 
this study that over 75% of food mediated intoxication was attributed to meat and 
poultry products (Wieneke et al. 1993). Ham, probably because of its high salt 
content and slow thermal processing times, appears to be a common meat 
source for Staphylococcal foodborne illness worldwide (Wieneke et al. 1993, 
Ward et al. 1997).  
Fermented and dried sausages are also a potential ideal medium for 
Staphylococcal and enterotoxin contamination caused from improper 
fermentation rates (AMI 1997). Since S. aureus does not compete well with other 
microorganisms and is tolerant of a wide range of intrinsic factors (pH and aw), 
processed meats serve as an ideal growth medium for S. aureus due to the lack 
of competing microflora (Daly et al. 1973, Lowy 2010).  
Prevention of S. aureus foodborne illness 
 Since little medical treatment is available for patients experiencing 
symptoms of food intoxication, prevention of the affliction is a far better option. 
Prevention of S. aureus foodborne illness begins with sanitation. According to 
Bennett and Lancette (2001), S. aureus and SE in food is “generally an indication 
of poor sanitation.” Many staphylococcal species have the ability to form biofilms 
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in a processing environment (Heilmann and Peters 2000). This makes sanitation 
more difficult.  
 Temperature control during storage and distribution of meat and meat 
products is critical to control the outgrowth of S. aureus and other pathogens 
(FDA 2001). Safe handling and prevention of temperature abuse during transport 
can prevent incidence of foodborne illness (Olsen et al. 2000, McCabe-Sellers 
2004). 
Sources of S. aureus contamination are numerous because of the ubiquity 
of the microorganism. Some common sources to contaminate meat and meat 
products include the following: livestock to be slaughtered, processing 
environments, food workers, home kitchens and consumers. With sources of the 
pathogen so numerous, personal hygiene is critical to prevent cross 
contamination of meat and meat products. Figure 2 graphically depicts the 
contributing factors attributing to foodborne illness in the United States from 
1993-1997 (McCabe-Sellers 2004). 
Antibiotic Resistant S. aureus 
Methicillin-resistant Staphylococcus aureus, also known as MRSA, is a 
variant strain of S. aureus that is also commonly found in the nasal passage, 
mucous membranes and on the skin of humans (Wenzel and Perl 1995, Zetola et 
al. 2005). MRSA is resistant to antibiotic therapies normally administered to 
combat S. aureus infections. Some of the therapies used for S. aureus include 
methicillin (no longer used in human medicine), penicillin and other beta-lactam 
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Figure 2. Contributing factors to foodborne outbreaks from 1993-1997.  
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antibiotics. MRSA strains that are resistant to three or more antibiotics are said to 
be multi-drug resistant and tend to be more virulent in nature than their methicillin 
sensitive (MSSA) relative. 
Methicillin and other β-lactam antibiotics 
 Methicillin, like most β-lactam antibiotics, is in the penicillin class of drugs 
that act on pathogenic microorganisms by preventing cell wall synthesis and 
causing cell death. Methicillin, or meticillin, was developed by George Rolinson 
and Ralph Batchelor in 1959 by a UK company, Beecham Research 
Laboratories, LTD. (Rolinson et al. 1960, Dutfield 2009). The “new penicillin (BRL 
1241)” was originally produced under the name “Celbenin” (methicillin) to treat 
penicillin resistant S. aureus infections (Knox 1960). Celbenin was soon replaced 
by oxacillin due to the severe nephritis and liver damage it caused in human 
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subjects. Although no longer utilized in human medicine, Celbenin (methicillin) is 
useful in determining drug sensitivities in laboratory studies. 
β-lactam antibiotics work to inhibit bacterial cell wall synthesis by binding 
to transpeptidase enzymes located on the surface of most gram positive bacteria 
(Waxman and Strominger 1983). These transpeptidase enzymes, also known as 
penicillin binding proteins (PBPs), allow cross-linking of the D-alanyl-alanine 
peptide that forms the peptidoglycan layer of the cell wall. PBPs have a higher 
affinity for β-lactams and result in competition for binding sites on PBPs. Once 
the PBP binding site is blocked, inhibition of cross-linking of the peptidoglycan 
layer occurs resulting in bacterial cell death (Tomasz 1979). S. aureus strains 
resistant to this antibiotic action have genetically and conformationally different 
PBP sites that decreases the sensitivity to the antibiotic.         
Mechanism for resistance 
 Resistance to an antibiotic by bacteria generally occurs through a change 
in the genetic make-up of the organism. Resistance genes can be translated 
vertically or horizontally. Vertical resistance results from a mutation to the genetic 
code responsible for, in the case of S. aureus, penicillin binding protein. This 
genetic mutation is in response to the antimicrobial agent being introduced into 
the organism’s environment. Horizontal mutation occurs when genes carried by a 
plasmid are introduced from outside of the cell resulting in the bacteria 
incorporating the genetic code for resistance (Fuda et al. 2004, Mayer 2010). 
 Resistant strains of S. aureus possess the Staphylococcal chromosomal 
cassette (SCC) mec gene. The mecA gene encodes for a variant penicillin 
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binding protein (PBP-2α) which is conformationally different from PBP of S. 
aureus strains sensitive to β-lactam antibiotics (Enright et al. 2002). PBP-2α has 
a lower affinity for penicillin antibiotics than that of regular PBP and is therefore 
“refractory of the action all available β-lactam antibiotics” (Fuda et al. 2004).   
History of MRSA 
 MRSA was first discovered in the UK in 1961, just two years after 
beginning clinical use of the drug methicillin (Enright et al. 2002). Discovery of 
MRSA in the United States did not occur until the late 1960’s at Boston City 
Hospital (Barrett et al. 1968). Since its discovery more than fifty years ago, 
MRSA has emerged as one of the leading and most severe infectious 
microorganisms acquired from exposure in health care settings (CDC 2003). 
MRSA colonization and infections have recently evolved from being solely 
acquired in a health care setting to that of a community acquired (CA) exposure 
(Zetola et al., 2005; Maree et al. 2007 and Witte et al., 2007). This means that 
transmission of MRSA from person-to-person outside of a medical facility is 
common. According to a review by Kluytmans et al. (1997), the nasal passage is 
a key harborage area for colonization of the bacteria, and it was estimated that 
10-15% of adults are continually colonized with MRSA (Wenzel and Perl, 1995).  
CA-MRSA cases tend to be less severe and more responsive to drug 
therapy than nosocomial MRSA infections (APHIS, 2007). MRSA infections are 
usually acquired through a wound, exposed skin or soft tissue areas. Clinical 
signs include furunculosis, multiple infected boils, and necrosis of the skin (Zetola 
et al., 2005). According to an article in the Journal of the American Medical 
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Association, the incidence of invasive MRSA infections in the United States is 
low (<1%) and prevalence varies by location (Klevens et al., 2007). Voss et al. 
(1994) reported that MRSA prevalence was highest in southern European 
countries (Spain, Italy and France) when compared to northern European 
countries (Denmark, Sweden and The Netherlands), which also suggests that 
geographic location may play a role in the incidence of MRSA cases. Although 
infection rates remain low, prevalence (colonization) and isolation of MRSA 
strains in the United States, especially community acquired cases, have 
increased dramatically since its discovery in the 1960’s. 
MRSA Confirmatory Testing and Identification 
 Multilocus sequence typing, or MLST, is commonly used to positively 
identify specific strains of unknown pathogens, including MRSA. This technology 
was proposed in 1988 by Maiden et al. (1998) as a “portable method” to confirm, 
identify and store sequence chromosomal DNA in a database for specific isolates 
(Maiden 2006). Polymerase chain reaction (PCR) is utilized to amplify a specific 
DNA section of internal genes (~ 450-500bp). For most bacteria, there are seven 
loci that are sequenced to generate a specific profile or sequence type for the 
unknown isolate. The allele sequence generated can then be compared to the 
database of known isolates to “unambiguously type” the pathogen (Urwin and 
Maiden 2003).     
 MRSA can also be positively identified by analyzing for presence of the 
mecA gene. The mecA gene, as previously discussed, is involved in the genetic 
encoding for a variant penicillin binding protein (2α) that inhibits the action of β-
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lactam antibiotics. The problem with the mecA gene solely used for identification 
of MRSA is that some strains still show clinical signs for resistance to methicillin 
and other β-lactams in the absence of this gene and PBP2α (Bignardi et al. 
1996). MLST results are more definitive, but are at a significant cost increase 
when compared to genetic testing for mecA.   
 A third confirmatory method for positively identifying MRSA is the luk 
gene. Panton-Valentine leukocidin, or PVL, is a virulence factor for some MRSA 
strains (CA-MRSAs). As previously discussed, leukocidin is a toxin secreted by 
the pathogen in two possible superantigen forms (lukS and lukF). These two 
exotoxins work synergistically to destroy white blood cells and by attacking soft 
tissues. According to Boubaker et al. (2004), PVL is carried by less than five 
percent of all known S. aureus isolates. This virulence factor has been linked to 
many antibiotic resistant strains of S. aureus causing CA-MRSA infections, 
necrotizing Pneumonia and other severe skin infections (Boubaker et al. 2004, 
Berglund et al. 2008).   
MRSA in Food Producing animals  
Although originally thought to be rare, MRSA has been isolated from 
companion animals and livestock, especially swine (APHIS 2007). The recent 
increase in community and livestock acquired MRSA cases throughout the world 
has caused epidemiologists to suggest a possible link to zoonotic transmission 
from animals to humans. Voss et al. (2005) showed a link between pigs at one 
location in The Netherlands and the family who lived and worked at the farm. A 
second MRSA case in The Netherlands was also examined by Huijsdens et al. 
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(2006) in which a mother with mastitis and no known risk factors for MRSA 
carriage was linked to a swine operation. In the study, 80% of the pigs sampled, 
three employees and all of the family members were found to have genetically 
identical strains of MRSA. Lewis et al. (2008) discussed the link to pig farming 
and the increased risk for MRSA exposure and subsequent infection in humans. 
More recently, Smith et al. (2009) reported a 49% MRSA prevalence in swine 
confinement operations in eastern Iowa and Illinois, along with a 45% carriage 
rate in farm employees. It is interesting to note from this pilot study that of the two 
production systems sampled, only one of the confinement systems was positive 
for MRSA in pigs and human subjects.  
In contrast to these results indicating a one-way zoonotic link between hog 
confinement operations and human disease, Price et al. (2012) describes an 
alternative theory to livestock and community associated MRSA in humans. This 
complicated genomic study clearly showed that a MRSA strain (CC 398) known 
to be associated with both swine and humans probably originated in humans. 
The study also refutes popular views on antibiotic overuse in livestock and 
explains the potential for a “bidirectional zoonotic exchange” between humans 
and livestock (Price et al. 2012). This ground breaking genetic work on MRSA 
transmission is the first and only report of its kind to date. 
Prevalence of MRSA in pork 
More alarming than a bacterium becoming part of a pig’s common nasal 
microflora is its potential effect on consumer perception and the world’s most 
popular meat commodity. Pork is the number one meat product consumed in the 
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world (USDA-FSIS, 2008), and U.S. pork consumption is around 51 pounds per 
person per year (USDA-ERS, 2005). Methicillin-sensitive Staphylococcus aureus 
(MSSA), a known foodborne pathogen, has been researched extensively in food 
for the intoxication it causes in humans. Very little, however, is known about its 
altered clone counterpart (MRSA) with respect to meat products.  
Recent research conducted has evaluated various meat products around 
the world to determine the prevalence of MRSA at the retail meat counter. Pu et 
al. (2009) found MRSA in 5.6% out of 90 pork products sampled in Louisiana 
retail food stores. A similar study in The Netherlands revealed MRSA present in 
2.5% out of 64 pork samples tested (van Loo et al., 2007). More recently, O’Brien 
et al. (2012) reported that 6.6% of 395 pork products purchased from retail 
outlets in Iowa, Minnesota and New Jersey were positive for MRSA. This study 
concluded no significant difference between MRSA or MSSA prevalence in retail 
pork and no differences between conventional and alternatively raised (raised 
without antibiotics) production schemes with regard to MRSA prevalence. These 
results seem to coincide with the theory suggested by Price et al. (2012) of 
MRSA’s bidirectional zoonotic pathway between humans and livestock.  
One of the first experiments to test for more than just presence or absence 
and actually quantify the contamination level of MRSA on retail pork products 
was performed by Weese et al. (2010). This investigation of Canadian retail meat 
products reported a prevalence of 9.6% out of 230 pork samples examined. Of 
the 22 pork products analyzed, 32% were below the detection limit of the assay 
and therefore were not quantifiable. Sixty percent of the positive MRSA samples 
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were ≤ 20 cfu/g, while only 27% were ≥ 30 cells per gram of meat. It is interesting 
to note from this study that 91% of the MRSA positive samples were from two of 
the four Canadian provinces sampled, which further supports the idea that 
geographical location may impact the risk of MRSA exposure. Ironically, 67% of 
Canada’s human population resides in these two provinces (Ontario and 
Quebec).  
In a larger geographical study of five heavily populated US cities, MRSA 
was isolated in almost 27% of the retail pork samples examined (Waters et al. 
2011). More concerning was the result that the MRSA-to-MSSA ratio was almost 
2:1, which further conflicts MRSA prevalence results. The research from Waters 
et al. (2011) is the highest MRSA prevalence report of its kind around the world. 
MRSA Causing Illness from Food 
 Although these studies in the North America and Europe indicate the     
presence of MRSA on pork products in retail meat outlets, transmission of MRSA 
as a food contaminant to humans is thought to be rare. The European Food 
Safety Authority’s Panel on Biological Hazards states that “there is no current 
evidence that eating or handling food” contaminated with MRSA will result in an 
infection (Byrne, 2009).  Epidemiologists at The University Hospital Rotterdam, 
Dijkzigt, The Netherlands, however believe a MRSA outbreak was initiated by a 
dietary worker who transferred the bacterium through food to patients (Kluytmans 
et al., 1995). This was the first report of its kind until Jones et al. (2002) linked a 
community acquired foodborne illness from MRSA to shredded pork barbeque in 
Tennessee. The report from Tennessee is the first to note that MRSA is also 
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capable of causing intoxication from enterotoxin produced in food. SE production 
from MRSA in food could be a greater risk than typical MRSA infections from 
contact. 
Disconnect Between Livestock & Human MRSA Strains  
 Since the discovery of MRSA ST398, the literature has focused in on this 
sequence type as being associated with livestock, especially pigs (Voss et al. 
2005, Huijsdens et al. 2006, Khanna et al. 2007, Witte et al. 2007, Lewis et al. 
2008, Smith et al. 2009 and Price et al. 2012). Although these findings of MRSA 
in pigs and pork indicate the presence and colonization of the pathogen, the 
results around the world do not necessarily parallel one another. For example, 
Weese et al. (2011) describes the “discordance between animal [strains of 
MRSA] and meat strains”. This study revealed that all MRSA strains recovered 
from meat samples were USA 100 (also known as Canadian epidemic MRSA-2), 
a known human pathogen, not the livestock associated ST398 strain (Weese et 
al. 2011). In a more recent examination of MRSA sequence types recovered from 
pork in the United States, only 18% of strains recovered were ST398 (Price et al. 
2012).  
The results from these investigations of MRSA in retail pork products in 
North America do not coincide with earlier work in Europe (VWA 2008, Boer et al. 
2009). In a study from the Netherlands, de Boer et al. (2009) concluded that 97% 
of isolates recovered from pork were ST398, a strain known to be associated 
with swine and swine production in Europe and North America. This disconnect 
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is cause for further confusion of MRSA prevalence in humans, livestock and 
meat.   
MRSA in the media 
With all of the evidence of increased MRSA prevalence and new emerging 
strains of this “super bug”, as described by New York Times columnist Nicholas 
Kristof (2009a), the question of how this is occurring is still of concern to both 
scientists and the general public alike. Kristof offered his opinion on the link to 
the increased MRSA colonization in pigs and people by describing the “insane 
overuse of antibiotics in livestock feeds” (Kristof 2009a). Findings of MRSA in our 
food sources also make for media opinionated opportunities like a New York 
Times article entitled “Pathogens in Our Pork” (Kristof 2009b). Katie Couric 
(2010) soon followed the paper media driven frenzy to investigate answers from 
animal agriculture personnel in her CBS evening news report entitled “Animal 
Antibiotic Overuse Hurting Humans?” In this report, she interviewed employees 
at a large hog confinement operation, as well as members of the scientific 
community to give their opinion of “extra label” feeding of antibiotics to pigs to 
promote health and productivity (Couric 2010). 
Prior to the Price et al. (2012) study, scientific literature and opinion filled 
media pieces alike seemed to indicate that modern food animal production 
practices were the only plausible explanation for the increased incidence of  
MRSA infections in our communities and now food. Regardless of the conflicting 
science, FDA still introduced a ban on the use of certain classes of human 
antibiotics (cephalosporin) in production animal agriculture (FDA 2012b). This 
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January 4, 2012 order went into effect April 5, 2012, and stops extra label uses of 
the drug in food producing animals for practices such as disease prevention. It is 
seemingly easy to overlook the fact that modern human medicine, not livestock 
production practices, created the original case for antibiotic resistance in 
Staphylococcal spp. more than forty years ago (Barrett et al. 1968).      
Summary of Literature 
Since its discovery in the early 1960’s, MRSA has emerged as a main 
pathogen of interest to human health professionals. Infections from antibiotic 
resistant bacteria are increasing around the world and have also been reported in 
food producing livestock. MRSA prevalence has also been recently reported in 
retail meat products around the world at rates higher than originally thought; 
however, the source of this contamination is a topic of scrutiny. Although 
contamination levels reported in meat are not fully understood, the risk of 
contracting an infection from handling contaminated meat products is thought to 
be low. Foodborne illness from MRSA has been reported as well, which should 
not be surprising since most S. aureus strains produce toxins to some degree. 
The fact that resistant strains of bacteria prove to adapt to stressors in their 
environment and mutate genetically to allow survival of future generations is 
concerning to scientists and the general public. Although numerous studies have 
been performed on the presence of MRSA in livestock and meat, very little is 
known about this organism from a food safety perspective. One main question 
arises from all of these reports of MRSA in our food sources. Do normal cooking 
or heating methods “kill” the bacteria? Therefore the purpose of the designed 
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study was to test the following objectives: 1) Determine the survival of methicillin-
resistant Staphylococcus aureus during thermal lethality processes used by 
commercial industry to prepare pork and pork products and 2) to determine the 
survival of methicillin-resistant Staphylococcus aureus during thermal lethality 
processes comparable to those used at the consumer level to prepare pork and 
pork products. 
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Abstract 
 
 Infections from antibiotic resistant bacteria are a major concern for human 
health professionals around the world. Methicillin-resistant Staphylococcus 
aureus (MRSA) is just one of the resistant organisms of concern. MRSA 
prevalence has also been recently reported in retail meat products at rates higher 
than originally thought. Although the risk of contracting an infection from handling 
contaminated meat products is thought to be low, very little is known about this 
organism from a food safety perspective. The objective of this study was to 
determine the survival of MRSA during thermal processing of frankfurters, 
summer sausage and boneless ham. Frankfurters, summer sausage and 
boneless ham were manufactured using formulations and processing procedures 
developed at the Iowa State University meat laboratory. Thermal processing 
resulted in a significant log reduction (P<0.05) for boneless ham, summer 
sausage and frankfurters when compared to uncooked, positive controls for each 
of the three processed meat products. All products were thermally processed to 
an internal temperature of 70°C and promptly cooled to 7.2°C. Boneless ham 
showed the highest log reduction (7.28 logs) from cooking, followed by summer 
sausage (6.75 logs) and frankfurters (5.53 logs). The results of this study indicate 
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that commercial thermal processing for ham, summer sausage and frankfurters is 
sufficient to reduce the risk of MRSA as a potential food safety hazard. 
_______________________________________________________________ 
1Department of Animal Science, Iowa State University, Ames, IA, USA. 
2Department of Food Science & Human Nutrition, Iowa State University, Ames, 
IA, USA.  
 
 
Introduction 
 Methicillin-resistant Staphylococcus aureus, also known as MRSA, is a 
variant strain of S. aureus, a known food pathogen and gram-positive cocci that 
commonly inhabits the nasal passage, mucous membranes and skin of humans. 
MRSA was first discovered in the United States in the 1960’s at Boston City 
Hospital (Barrett et al., 1968), and since its discovery more than forty years ago, 
MRSA has emerged as one of the leading and most severe infectious 
microorganisms acquired from exposure in health care settings (CDC NNIS 
system, 2003).  According to a recent article in the Journal of the American 
Medical Association, however, the incidence of invasive MRSA infections in the 
United States is low (<1%), and prevalence varies by location (Klevens et al., 
2007). Incidence of MRSA colonization and infections have evolved from being 
solely acquired in a health care setting to that of a community acquired exposure 
(Zetola et al., 2005; Maree et al. 2007 and Witte et al., 2007). Wenzel and Perl 
(1995) estimated that up to 10-15% of adults are continually colonized with the 
organism.  
MRSA has also been isolated from companion animals and livestock, 
especially swine (APHIS, 2007). Lewis et al. (2008) discussed the link to pig 
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farming and the increased risk for MRSA exposure and subsequent infections in 
humans. More recently, Smith et al. (2009) reported a 49% MRSA prevalence in 
swine confinement operations in eastern Iowa and Illinois, with a 45% carriage 
rate in farm employees. With the increase of MRSA colonization in livestock and 
people and invasive infections outside of a nosocomial setting, reasons for the 
increased incidences come into question. Opponents of animal agriculture offer 
their opinion on the link to the increased MRSA colonization and community 
acquired infections by describing the “insane overuse of antibiotics in livestock 
feeds” (Kristof, 2009). Price et al. (2012) refutes popular views on antibiotic 
overuse in livestock production and explains the potential for a “bidirectional 
zoonotic exchange” between humans and livestock. This means that humans 
can transfer potential resistant microorganisms to livestock and vice versa.  
Prevalence of MRSA has also been documented for numerous meat 
products, especially pork. Pork is the number one meat product consumed in the 
world (USDA-FSIS, 2008), and U.S. pork consumption is around 51 pounds per 
person per year (USDA-ERS, 2005). The recent research conducted evaluated 
various pork products around the world to determine the prevalence of MRSA at 
the retail meat counter. Pu et al. (2008) found MRSA in 5.6% out of 90 pork 
products sampled in Louisiana retail food stores. A similar study in The 
Netherlands revealed MRSA present in 2.5% out of 64 pork samples tested (van 
Loo et al., 2007). More recently, O’Brien et al. (2012) reported that 6.6% of 395 
pork products purchased from retail outlets in Iowa, Minnesota and New Jersey 
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were positive for MRSA. The majority of the literature suggests that MRSA 
contamination of meat products is very low (< 100 cfu/g detected).  
Although these studies in the United States and Europe indicate the 
presence of MRSA on pork products in retail meat outlets, transmission of MRSA 
as a food contaminant to humans is thought to be rare. The European Food 
Safety Authority’s Panel on Biological Hazards states that “there is no current 
evidence that eating or handling food” contaminated with MRSA will result in an 
infection (Byrne, 2009).  Epidemiologists at The University Hospital Rotterdam, 
Dijkzigt, The Netherlands, however believe a MRSA outbreak was initiated by a 
dietary worker who transferred the bacterium through food to patients (Kluytmans 
et al., 1995). This was the first report of its kind until Jones et al. (2002) linked a 
community acquired foodborne illness from MRSA to shredded pork barbeque in 
Tennessee. The report from Tennessee is the first to note that MRSA is also 
capable of causing classical S. aureus food poisoning from enterotoxin produced 
in food. The discovery that the strain causing the intoxication was MRSA was 
purely incidental. 
These results bring into question the safety of meat products with the 
increased incidence of MRSA at the retail level. Is it possible that MRSA with its 
genetic ability to be resistant to antimicrobials is also resistant to methods used 
to thermally process meat products?  To answer this question, the following 
study was designed to determine the survival of MRSA after thermal processing 
of various processed meat products. 
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Materials and Methods 
 Bacteriological Cultures.  Cultures of methicillin-resistant 
Staphylococcus aureus used for the designed experiment were obtained from 
Tara C. Smith at the Center for Emerging Infectious Diseases, University of Iowa 
College of Public Health, Iowa City, IA and from Catherine M. Logue at the 
Department of Veterinary Microbiology and Preventative Medicine, Iowa State 
University College of Veterinary Medicine, Ames, IA. The specific strains used 
during testing were ST398(HU010111N) from a 40 year old adult human male, 
t337(MN55) from an adult swine, ST398(R35) from retail ground pork and ATCC 
strain BAA-44(R31) as a reference organism. Cultures of each MRSA strain were 
grown at 35°C in Trypticase Soy Broth (TSB; Difco™, Becton, Dickson & Co., 
Franklin Lakes, NJ, USA) for 24 hours. The four strains were then combined and 
vortexed to create the mixed culture. 
 Frankfurter manufacture and inoculation. A blend of pork and beef 
emulsified and cooked sausages were made using formulations developed at the 
Iowa State University meat laboratory. The formula included the following 
ingredients: 90% lean beef trim (36.9% wt/wt), 50% lean pork trim (36.9% wt/wt), 
water (22.15% wt/wt), salt (1.5% wt/wt), 6.25% sodium nitrite curing salt (0.15% 
wt/wt) and spice blend (2.4% wt/wt). The frankfurter spice blend used was blend 
EJ-93-150-001 from A.C. Legg Packing Company (Calera, AL, USA). The pork 
and beef trim were ground through a 12.7mm plate using a Biro model 7552SS 
(Biro MFG Co., Marblehead, OH, USA) grinder. The emulsion was produced 
using a Krämer-Grebe model VSM65 (Krämer & Grebe GmbH & Co. KG., 
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Biendenkopf-Wallau, Germany) vacuum bowl chopper using six knives at varying 
speeds. The emulsion was then vacuum packaged and frozen at -28°C and 
stored until used for testing. 
A twenty-four hour culture of each MRSA strain was grown as previously 
described, and 4 ml were mixed with 36g of the emulsion batter. The inoculated 
batter was aseptically stuffed into a plastic 50mL Corning® centrifuge tube 
(Corning Inc., Corning, NY, USA) using a sterile plastic syringe. The screw cap 
was secured onto the centrifuge tube and placed into a three-tube centrifuge 
cassette. The cassette was then placed into a Thermo / NESLAB™ model RTE-
211 water bath / circulator (Thermo Scientific, Portsmouth, NH, USA) at 79.5°C 
with a 500g donut-style lead weight on top to keep the cassette submerged. The 
sausages were cooked to an internal temperature of 70°C and immediately 
transferred to a slush ice bath. The emulsified cooked sausages were cooled to 
7.2°C prior to microbial analysis. An uncooked, positive control was used to 
determine the inoculum level. A negative control, inoculated with 4mL of sterile 
TSB, was also created to monitor the internal temperatures of the sausage and 
to determine the presence of any naturally occurring mircoflora.   
Ten grams of each sausage (including positive and negative controls) 
were aseptically transferred to a Whirl-Pak® filter stomacher bag (Nasco, Ft. 
Atkinson, WI, USA) and stomached with 90mL of 0.1% buffered peptone water 
(Difco™, Becton, Dickson & Co., Franklin Lakes, NJ, USA) for 120 sec in a 
Seward model 400 lab blender stomacher (Seward Medical, London SE1 1PP, 
UK).The slurry was serially diluted as needed in buffered peptone water. 
 
50 
 
Appropriate dilutions (including the slurry contents) were surface plated in 
duplicate on Baird-Parker Agar with egg yolk Tellurite enrichment (BPA-EY; 
Difco™, Becton, Dickson & Co., Franklin Lakes, NJ, USA) and incubated at 35°C 
for 48hrs. Colonies were enumerated at 24 and 48 hours and the results were 
recorded. Three independent replications of this experiment were performed. 
 Summer Sausage Manufacture and Inoculation. A blend of pork and 
beef summer sausage was manufactured at the Iowa State University meat 
laboratory using the following formulation: 80% lean beef trim (47.17% wt/wt), 
80% lean pork trim (47.17% wt/wt), salt (1.89% wt/wt), water (1.42% wt/wt), 
dextrose (1.42% wt/wt), Newly Weds (Newly Weds Foods®, Inc., Chicago, IL, 
USA) summer sausage seasoning (0.47% wt/wt), Legg’s cure (A.C. Legg, 
Calera, AL, USA) 6.25% nitrite curing salt (0.23% wt/wt), SAGA® 200 
(Pediococcus acidilactici) (Kerry Seasoning, Beloit, WI, USA) lactic acid starter 
culture (0.23% wt/wt). The pork and beef trim were ground through a 9.5mm 
plate using a Biro model 7552SS grinder (Biro MFG Co., Marblehead, OH, USA). 
The ground trim was then transferred to a Hollymatic® model 175 mixer grinder 
(Hollymatic Corporation, Countryside, IL, USA) and mixed for 2 minutes along 
with the salt, water and curing salt. The dextrose, seasoning blend and starter 
culture dissolved into 300mL of distilled water was then added to the mixer 
grinder and mixed for an additional 2 minutes. The product was then reground 
through a 3.2mm plate and placed into vacuum pouches (Cryovac bag style, 
Cryovac-Sealed Air Corp., Duncan, SC, USA). The vacuum pouches were 
sealed and stored at -28°C until used for analysis.      
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 A four strain mixed culture of MRSA was prepared as previously 
described, and 5mL of each individual strain was combined in a test tube (20 mL 
total volume). The mixed culture was vortexed and mixed with 180g of the 
sausage batter. The inoculated batter was aseptically stuffed into a 250mL glass 
Pyrex® beaker (Corning Inc., Corning, NY, USA), covered with “Parafilm M” 
laboratory film (Bemis Flexible Packaging, Neenah, WI, USA) and placed into a 
45°C fermentation chamber for 12 hours. The fermented sausage was removed 
and the pH determined using a calibrated Accumet® model 15 pH meter (Thermo 
Fisher Scientific, Inc., Pittsburg, PA, USA). The fermented sausages were 
cooked in a Thermo / NESLAB™ model RTE-211 water bath / circulator (Thermo 
Scientific, Portsmouth, NH, USA) at 79.5°C and finished to an internal 
temperature of 70°C. The beakers were immediately transferred to a slush ice 
bath and cooled to 7.2°C prior to microbial analysis. An uncooked positive control 
was used to determine the inoculum level. A negative control, inoculated with 
20mL of sterile TSB, was also created to monitor internal temperatures of the 
sausages during cooking and chilling and to determine the presence of any 
naturally occurring mircoflora.   
Twenty five grams of each sausage after fermentation and thermal 
processing (including positive and negative controls) were aseptically transferred 
to a Whirl-Pak® filter stomacher bag and stomached with 225mL of 0.1% buffered 
peptone water for 120 seconds using a Seward model 400 lab blender 
stomacher and the slurry was serially diluted as needed. Each dilution (including 
the slurry contents) was surface plated in duplicate on BPA-EY and incubated at 
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35°C for 48hrs. Colonies were enumerated at 24 and 48 hours and the results 
were recorded. Three independent replications of this experiment were 
performed.  
Boneless Ham manufacture and inoculation. Pork inside and outside ham 
muscles obtained from swine harvested and fabricated at the Iowa State 
University meat laboratory were trimmed to remove surface connective tissue. 
The ham muscles were injected to 25% over raw weight using the following brine 
ingredients: water (80.7%wt/wt), salt (11%wt/wt), sugar (6.6%wt/wt), Brifisol® 450 
Super (BK Giulini Corp., Simi Valley, CA, USA) sodium phosphate (1.4%wt/wt), 
sodium erythorbate (0.22%wt/wt) and sodium nitrite (0.08%wt/wt). The pork 
insides and outsides were injected using a Günther® PI 21 model injector 
(Günther Maschinenbau GmbH, Dieburg, DE) and then macerated using a model 
PMT-41 Stork-Protecon™ macerator (Oss, Holland, The Netherlands). The ham 
macerate was vacuum sealed and stored at -28°C until used for testing.  
 A four strain mixed culture was prepared as previously described and 
3.5mL of each strain was combined in a test tube (14mL total volume). The 
mixed culture was vortexed and mixed with 1386g of the ham macerate. The 
inoculated ham was stuffed using a Biro DFS 30 (Biro MFG Co., Marblehead, 
OH, USA) piston stuffer. The ham was stuffed into a T8 x 30 inch pre-tied fibrous 
casing (Kalle UK Ltd., Witham, Essex, UK) and clipped using a Poly-Clip® 
System SCH 6210 model clipper (Poly-clip System GmbH & Co. KG, Frankfurt, 
Germany, DE). The hams were cooked in an Alkar® model 700 HP single truck 
 
53 
 
processing oven (ALKAR-RapidPak, Inc., Lodi, WI, USA) to an internal 
temperature of 70°C according to the schedule outlined in Table 1. 
 The cooked hams were immediately transferred to a 4°C walk-in cooler 
and chilled to 7.2°C in accordance with option 3 outlined in Appendix B, 
Compliance Guidelines for Cooling Heat-Treated Meat & Poultry Products 
(USDA-FSIS, 1999), prior to microbial analysis. An uncooked, positive control 
was used to determine the inoculum level. A negative control, inoculated with 
14mL of sterile TSB, was also created to monitor internal temperatures of the 
hams and to determine the presence of any naturally occurring mircoflora.   
Fifty grams of each ham after thermal processing and chilling (including 
positive and negative controls) were aseptically transferred to a Whirl-Pak® filter 
stomacher bag and homogenized with 450mL of 0.1% buffered peptone water for 
120 seconds using a Seward model 400 lab blender stomacher and the slurry 
was serially diluted as needed. Each dilution (including the slurry contents) was 
surface plated in duplicate on BPA-EY and incubated at 35°C for 48hrs. Colonies 
were enumerated at 24 and 48 hours and the results were recorded. Three 
independent replications of this experiment were performed.  
Data Analysis. Log10 transformations for surviving MRSA colonies were 
calculated in duplicate for each of three independent replications for frankfurter, 
summer sausage and boneless ham experiments. Values below the detection 
limit of the assay (<50 cfu/g) were recorded as the minimum detection limit for 
frankfurters, summer sausage and boneless ham. The frankfurter, summer 
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sausage and boneless ham experiments were arranged in a completely 
randomized design. Least significant differences (LSD) for the results were 
calculated using the general linear model procedure (PROC GLM) and the mixed 
effects model procedure (PROC MIXED) of the Statistical Analysis Software 
(SAS Institute Inc., Cary, N.C., USA) at a significance level of P < 0.05. 
Results 
 Frankfurters. Figure 1 graphically depicts the survival of MRSA in cooked, 
emulsified sausages. Table 2 shows the mean log10 count (cfu/g) and standard 
deviation for the negative control, positive control and cooked, inoculated 
treatments for the experiment. All three treatments were statistically different 
(P<0.001) from one another. There was an overall 5.5 log10 reduction in the 
cooked, inoculated samples when compared to the uncooked, positive control. 
As expected, populations of MRSA were not detected in the negative control.  
The average time for the frankfurters to reach an internal temperature of 70°C 
was 26.18 minutes with a range of 0.25 minutes. The average chill time in slush 
ice to an internal temperature of 7.2°C was 29.56 minutes with a range 6.56 
minutes. Cook and chill time for the experiment was not significant for the results 
of the main treatment effects.  
Fermented and cooked sausage (summer sausage). Figure 2 
illustrates the survival of MRSA in fermented and cooked sausages. Table 3 
shows the mean log10 count (cfu/g) and standard error for the negative control, 
positive control, fermented and cooked treatments for the experiment. All four 
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treatments were statistically different (P<0.001) from one another. There was an 
overall 6.75 log10 reduction in the cooked, inoculated samples when compared to 
the positive controls. As illustrated in the figure 3 and listed in table 4, growth did 
not occur in the negative control group.  The average starting pH of the raw 
sausages prior to fermentation was 6.02 with a range of 0.2. The average 12-
hour pH after fermentation was calculated to be 4.32 with a range of 0.05. The 
average time for the summer sausage to reach an internal temperature of 70°C 
was 39.95 minutes with a range of 7.97 minutes. The average chill time in slush 
ice to an internal temperature of 7.2°C was 52.35 minutes with a range of 12.3 
minutes. Cook / Chill times and pH were not significantly different between 
replications and did not impact the fixed main treatment effects. 
Boneless Ham. The results of the boneless ham experiment are shown in 
Figure 3. There was a significant effect (P<0.001) of the thermal treatment when 
compared to the uncooked, positive control. The total cooking process took an 
average of 5.5 hours and demonstrated an average Log10 reduction of 7.28. The 
cooked treatment means were not different (P=0.26) when compared to the 
negative control (ham with sterile TSB added). Day of replication was not a 
significant effect in the model (P=0.28). Chilling (stabilization) times of the hams 
to an internal temperature of 7.2°C ranged from 6.8 hours to 7.5 hours with an 
average time to stabilization of 7.15 hours. These times are well within the 15 
hour time limit for option 3 in FSIS-Appendix B (USDA-FSIS, 1999). Cook / Chill 
times were not a significant effect in the model. 
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Discussion 
 Frankfurters. The results of this study on survival of MRSA during 
thermal processing do not differ from the results of Heiszler et al. (1972) and 
Palumbo et al. (1977) on thermal inactivation of strains of S. aureus. These two 
studies differed in cook time to the described experiment above however, 
because they more closely mimicked large scale commercial manufacturing of 
frankfurters (30min vs. 95min). Heiszler et al. (1972) showed the greatest 
reduction of surviving microorganisms at an internal temperature of 60°C, but 
continued to decrease with increasing finished temperatures. It is interesting to 
note that S. aureus was only detected in 1.67% of the 120 frankfurters exposed 
to various time/temperature combinations. Although some of the frankfurters in 
these studies were exposed to higher ambient temperatures, addition of smoke 
and longer cook times than the water bath utilized in the current study, survival of 
MRSA is not different from S. aureus and should not be of great concern to 
consumers in these types of processed meats.  
 Fermented and cooked sausage (summer sausage). Since many 
strains of enterotoxin producing S. aureus have the ability to survive at varying 
salt concentrations, pH and water activities, these intrinsic and extrinsic factors 
are manipulated and monitored by meat processors during the production and 
storage of dry and semi-dry sausages. Results from Ingham et al. (2005) indicate 
that fermented, commercial summer sausages range in pH from 4.4 – 4.9 which 
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was slightly higher than pH measured in the current study. The survival of cells is 
not nearly as important as enterotoxin production in fermented sausages. Extent 
and rate of pH decline in fermented dry and semi-dry sausages appears to be 
main factors in controlling toxin production (Genigeorgis et al. 1969). Also S. 
aureus does not compete well with other bacterial populations (McCoy 1965) 
which suggests that dry and semi-dry sausages fermented with commercial 
starter cultures have a reduced risk of S. aureus growth and enterotoxin 
production. Appropriate fermentation procedures, as outlined by the American 
Meat Institute (AMI 1997), are vital for ensuring the safety of these processed 
meats.  
 Boneless Ham. Although thermal processing of large diameter meat 
products like ham can serve as potential growth reservoirs for S. aureus due to 
the slow come-up times of the product during cooking, the boneless ham results 
in this study showed the least survival for MRSA. Ingham et al. (2004) reported 
that although slow cooking procedures were adequate in controlling pathogen 
survival, control of S. aureus toxin production was paramount. Since some 
strains of MRSA are capable of producing enterotoxin, critical limits for time and 
temperature combinations like those validated by Ingham et al. (2004) should be 
considered for processed meats thermally processed using slow-cooking 
procedures.     
Conclusions 
 The results of this study indicate that commercial procedures used for 
thermal processing and subsequent chilling of frankfurters, summer sausage and 
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boneless ham allowed for at least a 5.5 log10 reduction of MRSA at 70°C. This is 
important when considering the risk of foodborne illness from MRSA in 
processed meats, since the literature indicates that MRSA contamination at the 
retail counter is very low (< 100 cells per gram of meat). Reduced pH products 
and larger diameter processed meats showed an increased safety level with 
regard to survival of MRSA. It is important to consider good manufacturing 
practices for fermentation degree-hours in reduced pH products fermented with 
starter cultures. Although acid production and subsequent thermal processing 
drastically reduce survival of viable organisms, improper fermentation procedures 
or failed fermentations could allow for ideal conditions for enterotoxin production 
by MRSA. Adequate temperature control, proper sanitation and prevention of 
cross contamination by food handlers are still the main components for reduced 
risk of foodborne illness by a microorganism like MRSA. 
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Figure 1. Survival of MRSA in Frankfurters Cooked to an Internal 
temperature of 70°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Survival of MRSA in Fermented and Cooked Summer Sausage. 
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Figure 3. Survival of MRSA in Boneless Ham Cooked to 70°C 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
5.5
6
6.5
7
7.5
8
8.5
24 48
Hours
Lo
g1
0
 c
fu
/g
pos. control
cooked 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
 
 
 
 
 
Table 1. Boneless Ham Thermal Processing Schedule 
Step Time D.B. W.B. Humidity IT (°F) Dampers 
Cook 0:40 165 0 0%  Auto 
Cook 0:30 170 0 0%  Auto 
Cook 0:45 175 0 0%  Closed 
Cook 1:00 175 161 71% 126 Closed 
Cook 0:01 180 160 62% 140 Auto 
Steam Cook 0:01 185 185 100% 158 Closed 
Cold Shower 0:10 50 50 0%  Auto 
 
 
Table 2. Mean and standard error of mean for survival of MRSA in 
frankfurters 
Treatment Means (Log10 CFU/g) 
Negative 0a 
Positive 7.76 ± 0.10b 
Cooked (79.5°C) 2.23 ± 1.06c 
a-cMeans in a column with different superscripts are statistically different (P<0.05) 
 
 
Table 3. Mean and standard error for survival of MRSA in summer sausage 
Treatment Means (Log10 CFU/g) 
Negative 0a 
Positive 7.75 ± 0.09b 
Fermented (45°C) 3.75 ± 0.32c 
Cooked (79.5°C) 0.93 ± 0.69d 
a-dMeans in a column with different superscripts are statistically different (P<0.05) 
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Table 4. Mean and standard error of mean for survival of MRSA in boneless 
ham 
Treatment Means (Log10 CFU/g) 
Negative 0a 
Positive 7.73 ± 0.24b 
Cooked (79.5°C) 0.45 ± 0.73c 
a-cMeans in a column with different superscripts are statistically different (P<0.05) 
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CHAPTER 4. SURVIVAL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS 
AUREUS DURING COMMERCIAL HEAT TREATMENT OF SLAB BACON          
AND CONSUMER PREPARATION OF SLICED BACON 
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Jonathan A. Campbell1, Joseph C. Cordray1, James S. Dickson1, Dennis Olson1, 
Aubrey F. Mendonca2 and Kenneth J. Prusa2 
 
Abstract 
 With the knowledge that retail pork products may be contaminated with 
methicillin-resistant Staphylococcus aureus (MRSA), the risk of consumers 
contracting a MRSA infection or foodborne illness from processed meats, 
especially bacon, is uncertain. Therefore, a study was designed to investigate the 
survival of MRSA during heat treatment of slab bacon at a commercial process and 
during cooking of sliced bacon at the consumer level. Fresh pork bellies were 
injected with a curing solution, inoculated and heat treated to an internal 
temperature of 52°C. Three commercial brands of sliced bacon with similar “sell-
by” dates and fat-to-lean ratios were also inoculated and cooked at a temperature 
of 177°C for 0, 2 and 5 minutes on each side. Heat treated slab bacon showed a 
log reduction of 1.89, which was significant (P<0.05) when compared to an 
uncooked, inoculated control. Cooked sliced bacon had a reduction of viable 
MRSA cells > 6.5 logs, and there was not a significant brand interaction (P>0.05).  
_________________________________________________________________ 
1Department of Animal Science, Iowa State University, Ames, IA, USA. 
2Department of Food Science & Human Nutrition, Iowa State University, Ames, IA, 
USA. 
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Introduction 
 The popularity, sales and utilization of bacon made from pork bellies has 
increased dramatically in recent years in the United States. Sales of the top 20 
retail bacon brands in the U.S. surged pass the $2 billion dollar mark in 2010 (1). 
The majority of retail bacon sold in the U.S. is uncooked, sliced and vacuum 
packaged for consumers to store and cook at home. According to the National Pork 
Board (8), bacon accounts for 19% of pork eaten in the home and is prepared in 
the home by pan frying on the stove top 45% of the time.  
 Unfortunately, another statistic of interest to pork producers and meat 
processors alike is the seemingly growing presence of antibiotic resistant 
pathogens detected throughout the pork production and distribution chain. MRSA is 
one of the main pathogens of interest linked to pork production, and a 2008 study 
outlined the risk for MRSA exposure and potential increased chance of infections in 
humans from swine production (7).  Clinical signs of MRSA infections include 
furunculosis, multiple infected boils, and necrosis of the skin (17). A 2007 article in 
the Journal of the American Medical Association, however, reported that the extent 
of invasive MRSA infections in the U.S. is generally <1% (5). The connection 
between pig farming and MRSA exposure and carriage by humans is worldwide 
(15, 4, 11). Voss et al. (14) reported that MRSA prevalence was highest in 
southern European countries (Spain, Italy and France) when compared to northern 
European countries (Denmark, Sweden and The Netherlands), which also 
suggests that geographic location may play a role in the incidence of MRSA cases. 
Although infection rates in humans remain low, colonization and isolation of MRSA 
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strains linked to livestock production have increased dramatically since its 
discovery in the 1960’s.  
 MRSA has also been detected in pork products in retail meat products 
around the world. An experiment in the Netherlands concluded that MRSA was 
prevalent in 33 out of 309 (10.7%) pork samples tested (2). Similar results were 
reported for retail pork products in Canada and the United States (10, 16, 9). 
Although these results from Europe and North America indicate the presence of 
MRSA in livestock and retail meats, the impacts these discoveries have on human 
health and food safety are not well understood. 
 Although the U.S. has seen an increase in both bacon sales and the 
prevalence of MRSA in retail pork products, very little is known about the risk of 
infection to consumers or foodborne illness caused by MRSA from consuming 
bacon. The objective of the following experiment was to investigate the survival of 
methicillin-resistant Staphylococcus aureus during commercial heat treatment of 
cured pork bellies and during cooking of sliced bacon at the consumer level.        
Materials and Methods 
 Bacteriological Cultures.  Cultures of methicillin-resistant Staphylococcus 
aureus used for the designed experiment were obtained from Tara C. Smith at the 
Center for Emerging Infectious Diseases, University of Iowa College of Public 
Health, Iowa City, IA and from Catherine M. Logue at the department of Veterinary 
Microbiology and Preventative Medicine, Iowa State University College of 
Veterinary Medicine, Ames, IA. The specific strains used during testing were 
ST398(HU010111N) from a 40 year old adult human male, t337(MN55) from an 
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adult swine, ST398(R35) from retail ground pork and ATCC strain BAA-44(R31) as 
a reference organism. Cultures of each MRSA strain were grown at 35°C in 
Trypticase Soy Broth (TSB; Difco™, Becton, Dickson & Co., Franklin Lakes, NJ, 
USA) for 24 hours. The four strains were then combined and vortexed to create the 
mixed culture. 
Slab Bacon manufacture and inoculation. Fresh, skinless pork bellies 
ranging in thickness from 2.38 – 2.71 cm were obtained from swine harvested and 
fabricated at the Iowa State University meat laboratory. The bellies were injected to 
12% over raw weight using the following brine ingredients: water (79.5%wt/wt), salt 
(12.75%wt/wt), sugar (4.25%wt/wt), Brifisol® 512 Super (BK Giulini Corp., Simi 
Valley, CA, USA) sodium phosphate (2.94%wt/wt), sodium erythorbate 
(0.458%wt/wt) and sodium nitrite (0.10%wt/wt). The pork bellies were injected 
using a Günther® PI 21 model injector (Günther Maschinenbau GmbH, Dieburg, 
Germany, DE). The injected bellies were vacuum sealed and stored at      -28°C 
until used for testing.  
 A twenty-four hour culture of each MRSA strain was grown at 35°C in TSB. 
A four strain mixed culture was prepared as previously described by transferring 
1mL of each strain into a test tube and vortexing. Each belly slab was scored with 
six – 5cm x 5cm squares. Three of the 25cm2 sections were scored on the lateral 
(skin) side and three 25cm2 sections were scored on the medial (rib) side. 100µL of 
the four strain mixed culture was spread over four of the 25cm2 scored belly 
surfaces (two lateral and two medial) with a sterilized glass “hockey stick” 
spreader. The inoculated bellies were allowed to dry for 30 minutes at 22°C 
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(method modified from Burnham et al.(3)) prior to being heat treated in an Alkar® 
model 700 HP single truck processing oven (ALKAR-RapidPak, Inc., Lodi, WI, 
USA) to an internal temperature of 52°C according to the schedule outlined in 
Table 1. The slab bacon was stabilized in a 4°C walk-in cooler to an internal 
temperature of 7.2°C in accordance with option 3 outlined in Appendix B, 
Compliance Guidelines for Cooling Heat-Treated Meat & Poultry Products (13). 
Each of the six 25cm2 sections (approximately 50g) were excised using a 
sterile scalpel, aseptically transferred to a Whirl-Pak® filter stomacher bag (Nasco, 
Ft. Atkinson, WI, USA) and filled with 450mL of 0.1% buffered peptone water 
(BPW; Difco™, ) (method modified from Burnham et al. (3)). One 25cm2 section 
from each side (medial and lateral) was inoculated and excised prior to thermal 
processing and chilling to evaluate the initial inoculum level (positive control).  One 
25cm2 section from each side (medial and lateral) was inoculated with sterile TSB 
to serve as a negative control and to detect the presence of any naturally occurring 
mircoflora. Figure 1 depicts the locations of the six 25cm2 sections on the belly 
surface. 
The contents of the filter bag were mixed for 120 seconds using a Seward 
model 400 lab blender stomacher (Seward Medical, London SE1 1PP, UK) and the 
slurry was serially diluted as necessary in BPW.  Appropriate dilutions (including 
the slurry contents) were surface plated in duplicate on Baird-Parker Agar with egg 
yolk Tellurite enrichment (BPA-EY; Difco™, Becton, Dickson & Co., Franklin Lakes, 
NJ, USA) and incubated at 35°C for 48hrs. Colonies were enumerated at 24 and 
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48 hours and the results were recorded. Three independent replications of this 
experiment were performed.  
Sliced Bacon inoculation and sampling. Three brands of commercially 
available sliced bacon, selected on the basis of similar “use by” dates and fat-to-
lean ratios were purchased at local retail outlets in Ames, IA and brought back to 
the Iowa State University food safety research laboratory for testing and evaluation.  
A four strain mixed culture was prepared as previously described, and 
2.5mL of each strain was transferred into a test tube (10mL total volume) and 
vortexed. Two 25g slices of bacon from each brand were inoculated on both sides 
with 0.5mL of the mixed culture. Two degrees of doneness, “very crispy” and “less 
crispy” were used to evaluate the survival of MRSA during cooking of sliced bacon. 
“Very crispy” slices were grilled on a 16-inch, covered Presto® electric skillet 
(National Presto Industries, Inc., Eau Claire, WI) at 177°C (350°F) for 5 minutes on 
each side. “Less crispy” bacon slices were grilled on the same skillet for 2 minutes 
on each side. 10g of each brand of cooked bacon for the two doneness variables 
were aseptically transferred to a Whirl-Pak® filter stomacher bag and homogenized 
with 90mL of BPW for 120 seconds using a Seward model 400 lab blender 
stomacher. The slurry was serially diluted as necessary in BPW, surface plated in 
duplicate on BPA-EY and incubated at 35°C for 24 hours. Colonies were 
enumerated for growth and recorded. The remaining portion of cooked bacon 
slices from each brand for the two doneness variables were placed into a test tube 
of Brain Heart Infusion broth (BHI, Difco™) enrichment and incubated at 35°C for 
24 hours. The incubated BHI was then streaked onto BPA-EY plates to test for 
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presence or absence of severely heat injured MRSA requiring time and enrichment 
to recover.  
Data Analysis. Log10 values for surviving MRSA colonies were calculated in 
duplicate for each of three independent replications for sliced and slab bacon 
experiments. The detection limit for the assay was 50 cfu/g for both slab and sliced 
bacon experiments. The slab bacon and sliced bacon experiments utilized a 
randomized complete block design to interpret the data and block for location and 
side of the belly slab (lateral or medial) and brand of sliced bacon used in the 
study. A value of zero was entered when no growth was detected. Least significant 
differences (LSD) for the results were calculated using the general linear model 
procedure (PROC GLM) and the mixed effects procedure (PROC MIXED) of the 
Statistical Analysis Software program (SAS Institute Inc., Cary, N.C., USA) at a 
significance level of P < 0.05.  
Results and Discussion 
 Slab Bacon. The results of the slab bacon study are illustrated in Figure 2, 
as well as the means summarized in Table 2. The results of the experiment show 
average log10 reduction of 1.89 when comparing the fixed main treatment effects of 
heat treatment to the uncooked, positive control. These results are similar to a 
study by Taormina and Bartholomew (12) who reported a 1.26 log10 reduction after 
smoking and subsequent chilling of whole belly pieces. It should be noted that 
whole belly pieces in this similar report were heat treated to a lower temperature 
(48.9°C) which could explain the smaller reduction in population. Although not 
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examined in the current study, the addition of smoke to whole cured pork bellies 
inhibits both S. aureus growth and enterotoxin production. (12)  
Although not significantly different (P=0.21) from the medial side negative 
control group (MS neg con), there was observed growth on the lateral side 
negative control group (SS neg con). Day of replication was a significant factor in 
the model (P=0.01), so the mixed effect day within treatment interaction was added 
to the statistical model. This term in the model may explain the observed growth for 
SS neg con, which means contamination of the sample could have occurred for 
that particular group. The block of location on the belly was not significantly 
different (P>0.05) within the main treatment effects and did not significantly impact 
the fixed main treatment effect of cooking. The average time for heat treatment to 
an internal temperature of 52°C was 5.9 hours ±0.7 hours. Average chill time for 
stabilization was 8.4 hours. Cook / Chill times were not a significant factor to 
explain the data. Cook and chill times differ from commercial processes reported in 
the literature (12). The time difference is mainly due to the blast chill devices 
utilized in commercial bacon operations to rapidly chill and crust whole, cured and 
smoked bellies prior to slicing.   
 Sliced Bacon. The results for the survival of MRSA on sliced bacon cooked 
at a temperature of 177°C (350°F) are shown in Figure 3. The means of observed 
growth for the experiment are listed in Table 3.  There was not a significant 
difference (P>0.05) between brands or for the brand within treatment effect (cook 
time) in the model. Day of replication also did not impact the fixed main treatment 
effect of time of cooking (0, 2 or 5 minutes @ 177°C). Overall, the three 
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independent replications showed a Log10 reduction of > 6.5. There was not a 
significant difference (P=0.91) in the treatment effect between cooking at 2 minutes 
per side or 5 minutes per side, but were different (P<0.001) when compared to the 
uncooked, positive control. Although not measured in the current study, the 
literature suggests that water activity is a better measure of safety of cooked sliced 
bacon with respect to S. aureus growth and toxin production (6). 
Figure 4 shows the results of the percent positive MRSA samples observed 
from a Brain Heart Infusion (BHI) enrichment of cooked pieces. The percent 
positive results were pooled by treatment only since there was not a significant 
difference between brands in the model. The pooled Least Square Means 
(LSMeans) ± standard errors of the means for the percent positive results for the 
BHI enrichment are listed in Table 4. Although not statistically different, recovery of 
MRSA from BHI enrichment was not observed in Brand A.  
These results indicate that some samples were potentially positive for viable 
MRSA cells below the detection limit of the assay (50 cells/g). The survival of 
MRSA from heat injured cells could also explain the results from the enrichment 
experiment. This could be a result of the bacteria being exposed to a high 
temperature for shorter periods of time. It is obvious; however that sliced bacon 
grilled at high temperatures is sufficient to greatly reduce the risk of MRSA survival.    
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Figure 1. Schematic of bacon slab 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Survival of MRSA in slab bacon heat treated to 52°C 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
5.5
6
6.5
7
7.5
24 48
Hours
Lo
g1
0 
cf
u/
g
MS pos con
SS pos cont 
MS trt
SS trt
SS neg con
 
Bacon hanger 
Medial side 
Lateral side 
 78 
 
 
Figure 3. Survival of MRSA in sliced bacon cooked at 177°C (350°F) 
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Figure 4. Percent positive MRSA in sliced bacon samples after cooking and 
BHI enrichment 
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Table 1. Slab Bacon Thermal Processing Schedule 
Step Time D.B. W.B. Humidity IT (°F) Dampers 
Cook 2:00 104 86 48%  Auto 
Cook 1:00 125 100 42%  Closed 
Cook 1:30 125 0 0%  Auto 
Cook 0:01 135 100 30% 126 Auto 
  
 
Table 2. Mean and standard error of mean for survival of MRSA in slab bacon 
Treatment Means (Log10 CFU/g) 
MS Negative 0a 
SS Negative 0.81 ± 1.15a 
MS Positive 6.45 ± 0.49b 
SS Positive 6.44 ± 0.46b 
MS Treatment 4.48 ± 1.01c 
SS Treatment 4.61 ± 1.07c 
a-cMeans in a column with different superscripts are statistically different (P<0.05) 
MS = medial side of belly 
SS = lateral (skin) side 
 
 
Table 3. Mean and standard error of mean for survival of MRSA in sliced 
bacon 
 Time (minutes) 
Brand 0 2 5 
A 7.05 ± 0.02d 0e 0e 
B 7.02 ± 0.05d 0e 1.05 ± 1.82e 
C 6.86 ± 0.11d 1.20 ± 2.08 e 0e 
d-eMeans in a column with different superscripts are statistically different (P<0.05) 
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Table 4. LSMean and standard error of mean for pooled data of percentage of 
MRSA present in sliced bacon after BHI enrichment 
Time (minutes) LSMEAN ± Standard Error Mean (n=27) 
0 100 ± 0.13a 
2 44.44 ± 0.13b 
5 22.22 ± 0.13b 
a-bMeans in a column with different superscripts are statistically different (P<0.05) 
 81 
CHAPTER 5. GENERAL CONCLUSIONS 
 Consumers are constantly bombarded with the knowledge of potential 
pathogens in their environment through sometimes false and misleading modern 
media sources. As our world becomes more internet driven and scientists seek 
factual answers to consumer health concerns, caution must be taken in analyzing 
the true risk involved in a situation. For example, consumers should be well 
informed of the risk involved in eating undercooked meat and poultry products, 
yet this practice still occurs in modern societies today. Foodborne disease can 
devastate the credibility of an entire industry if appropriate controls for these risks 
are not in place. Primitive man understood that his food from a recent kill of a 
beast had a prolonged shelf life if he used fire to cook. Unfortunately, our world is 
much more complex than that of primitive human societies; however, we still face 
similar challenges with regard to the safety and security of our food supply.  
 Societies today are faced with the presence of genetically mutated 
microorganisms that threaten our health, food supply and modern way of life. 
Prior to this study, only the knowledge that antibiotic resistant Staphylococcus 
aureus was prevalent in meat and poultry products available to consumers at the 
retail counter. Furthermore, consumers were left to decide for themselves if this 
genetic mutation we call MRSA survived various cooking practices.  
Results from this research indicate that methods used to commercially 
thermal process frankfurters, summer sausage and boneless ham to an internal 
temperature of 70°C dramatically reduce the presence of MRSA in these 
processed meat items. In addition to thermal processing, acid production during 
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fermentation and subsequent pH reduction to below 5.0 in summer sausage 
greatly reduced MRSA survival of viable cells. Although the results of the slab 
bacon heat treated to an internal temperature of 52°C indicate a higher rate of 
MRSA survival, the overall lethality of the heat treatment process could be 
sufficient to adequately reduce the risk of MRSA exposure to the consumer from 
MRSA populations reported in the literature. Regardless of the perceived risk to 
consumers, bacon sold at the retail level is handled as an uncooked item and 
labeled with safe handling instructions to consumers similar to that of raw meat 
items. As a result, studies were conducted to evaluate the effectiveness of 
consumers frying sliced bacon in the home. Results from the simulated 
consumer frying treatment indicate very low MRSA survival rates regardless of 
“doneness” level. Although MRSA proves to be a hardy organism with respect to 
antibiotic resistance, these studies indicate that MRSA is inhibited by various 
types and temperatures of thermal processing.  
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